DRUG

AMD3100

3 hypotheses across 2 therapeutic domains

ALL HYPOTHESES

Repurposing candidates for AMD3100

Glioblastoma 1

Mediator Outcome Score Tier Lit. status Trial
CXCR4 PCNSL 0.208 Mid partial evidence none

Rheumatoid arthritis 2

Mediator Outcome Score Tier Lit. status Trial
CXCR4 chondrocyte senescence 0.208 Mid novel signal none
CXCR4 Osteoarthritis 0.208 Mid reproduces known none

Clinical trials

0 registered trials for AMD3100

Source: ClinicalTrials.gov

No registered trials found on ClinicalTrials.gov. This could indicate either an unexplored indication or a gap in registry coverage.

Search ClinicalTrials.gov →